Status:
COMPLETED
Gene Analysis in Studying Susceptibility to Wilms Tumor
Lead Sponsor:
Children's Oncology Group
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Recurrent Childhood Kidney Neoplasm
Stage I Kidney Wilms Tumor
Eligibility:
All Genders
Brief Summary
This clinical trial studies gene analysis in studying susceptibility to Wilms tumor. Finding genetic markers for Wilms tumor may help identify patients who are at risk of relapse.
Detailed Description
PRIMARY OBJECTIVES: I. To use a genome-wide association analysis to identify novel genetic variants that confer susceptibility to Wilms tumor. II. To improve our understanding of the genetic archite...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- 3000 samples from the 1958 Birth Cohort (58C) and 3000 from the UK Blood Service control series (NBS)
Exclusion
Key Trial Info
Start Date :
October 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 1 2009
Estimated Enrollment :
1 Patients enrolled
Trial Details
Trial ID
NCT01808079
Start Date
October 1 2009
End Date
November 1 2009
Last Update
August 22 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Childrens Oncology Group
Philadelphia, Pennsylvania, United States, 19104